The Portuguese Institute of Blood and Transplantation (IPST, IP) created in 2012, is the result of the merger of the Portuguese Blood Institute (3 Regional Blood Centres), with the 3 Histocompatibility Centres, and part of transplantation regulatory functions of the former Competent Authority.
IPST, IP ensures the collection, processing, storage and distribution of blood and blood components of approximately 60% of the blood collection in Portugal (about 200.000 units per year, 80% in mobile venues). The remaining 40% of blood collection in Portugal is by hospital blood establishments, all 100% voluntary non remunerated blood donation.
Since 2010, IPST, IP produces and distributes PR/ Intercept treated Platelets, and since 2014, Portuguese PR/ Intercept treated Plasma and Portuguese SD Plasma.
Self-sufficiency and safety for patients, training and education and efficiency are IPST IP governance principles.
The management of Portuguese Haemovigilance and Biovigilance Systems lies within the scope of responsibili¬ties of IPST IP as well as the Portuguese Unrelated Bone Marrow Donors Registry (CEDACE), the Public Cord Blood Bank (BPCCU), the Multiorganic Tissue Bank, the National Coordination of Organ Transplantation and the Histocompatibility laboratory activities namely for Transplantation donor/ recipient pairs.
Instituto Português do Sangue e da Transplantação
Av Miguel Bombarda, 6
1000-208 Lisboa, Portugal